Literature DB >> 6514591

Varicella: clinical manifestations, epidemiology and health impact in children.

S R Preblud, W A Orenstein, K J Bart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514591

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


× No keyword cloud information.
  20 in total

Review 1.  Vaccines for tomorrow.

Authors:  S K Sood
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.

Authors:  G P Garnett; B T Grenfell
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

Review 3.  Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.

Authors:  Kristine Macartney; Anita Heywood; Peter McIntyre
Journal:  Cochrane Database Syst Rev       Date:  2014-06-23

4.  School and daycare exclusion policies for chickenpox: A rational approach.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-05       Impact factor: 2.253

5.  Impact and costs of varicella prevention in a university hospital.

Authors:  D J Weber; W A Rutala; C Parham
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

6.  Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study.

Authors:  S Kuhn; H D Davies; T Jadavji
Journal:  Can J Infect Dis       Date:  1997-11

7.  Complications of varicella in a defined central European population.

Authors:  A Jaeggi; R P Zurbruegg; C Aebi
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

8.  Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010.

Authors:  Daniel Mimouni; Hagai Levine; Anat Tzurel Ferber; Inbal Rajuan-Galor; Michael Huerta-Hartal
Journal:  Hum Vaccin Immunother       Date:  2013-02-14       Impact factor: 3.452

9.  The seroprevalence of varicella zoster antibodies in Behçet's and other skin diseases.

Authors:  Sedat Akdeniz; Mehmet Harman; Selahattin Atmaca; Nezahat Akpolat
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

10.  The burden of varicella in Germany. Potential risks and economic impact.

Authors:  Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Thomas Hammerschmidt; Peter Wutzler
Journal:  Eur J Health Econ       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.